SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-16-012500
Filing Date
2016-08-15
Accepted
2016-08-15 17:17:48
Documents
43
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 468384
2 ex31-1.htm EX-31.1 8105
3 ex31-2.htm EX-31.2 8095
4 ex32-1.htm EX-32.1 5018
5 ex32-2.htm EX-32.2 4925
  Complete submission text file 0001493152-16-012500.txt   1890060

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE obmp-20160630.xml EX-101.INS 190427
7 XBRL SCHEMA FILE obmp-20160630.xsd EX-101.SCH 25987
8 XBRL CALCULATION FILE obmp-20160630_cal.xml EX-101.CAL 31642
9 XBRL DEFINITION FILE obmp-20160630_def.xml EX-101.DEF 85962
10 XBRL LABEL FILE obmp-20160630_lab.xml EX-101.LAB 182492
11 XBRL PRESENTATION FILE obmp-20160630_pre.xml EX-101.PRE 131983
Mailing Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809
Business Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809 225-227-2384
OncBioMune Pharmaceuticals, Inc (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52218 | Film No.: 161833935
SIC: 7310 Services-Advertising